Sherbrooke Park Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SSR Mining
SSRM
|
+$4.08M |
| 2 |
Amylyx Pharmaceuticals
AMLX
|
+$3.92M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
+$2.98M |
| 4 |
Lennar Class A
LEN
|
+$2.74M |
| 5 |
Dow Inc
DOW
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$2.12M |
| 2 |
HOLX
Hologic
HOLX
|
+$2.01M |
| 3 |
Marathon Petroleum
MPC
|
+$1.66M |
| 4 |
Coca-Cola
KO
|
+$1.58M |
| 5 |
Jabil
JBL
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.07% |
| 2 | Industrials | 18.09% |
| 3 | Consumer Discretionary | 13.93% |
| 4 | Healthcare | 10.29% |
| 5 | Financials | 9.04% |
Similar funds
Sherbrooke Park Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, Sherbrooke Park Advisers held 1,025 positions worth $514M, up 141% from $213M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
Sherbrooke Park Advisers deployed $293M of net new capital in Q1 2024, opening 585 new positions and adding to 167 existing holdings. Its largest new stake was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Procter & Gamble, an estimated $2.12M trimmed.
- Sherbrooke Park Advisers's largest Q1 2024 buy was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
- Sherbrooke Park Advisers added most to SSR Mining in Q1 2024, an estimated $4.08M increase.
- Sherbrooke Park Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $2.12M.
- Sherbrooke Park Advisers fully exited Hologic in Q1 2024, selling an estimated $2.01M.
- Sherbrooke Park Advisers's ten largest holdings make up 5.5% of its $514M portfolio in Q1 2024.
- Sherbrooke Park Advisers opened 585 new positions and closed 207 in Q1 2024.
- Sherbrooke Park Advisers's portfolio value rose 141% quarter-over-quarter to $514M.
Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.